Abstract:Bioactive phospholipids (PL) from different origins varied greatly in the chemical constitutions, especially the fatty acid compositions, which might influence its physiological activities in turn. In the study, egg yolk phospholipids (EGG‐PL), soybean phospholipids (SOY‐PL), and marine docosahexaenoic acid‐enriched phospholipids (DHA‐PL) were administered to high fat (HF) diet‐induced obese C57BL/6J mice for 7 weeks to compare their effects on obesity‐related metabolic disorders. EGG‐PL, SOY‐PL, and DHA‐PL significantly decreased epididymal adipose tissue weights, reduced blood pressures and lowered hepatic TG levels. Only DHA‐PL efficiently decreased perirenal adipose tissue weights, and reduced serum glucose, insulin, IL‐6 and TG levels. These three phospholipids significantly decreased delta‐9 desaturation indices, the ratio of oleic acid versus stearic acid, and reduced the enzyme activities and gene expressions of FAS in the liver, while DHA‐PL also markedly reduced mRNA levels of SREBP‐1c and SCD‐1. Hepatic total catalase and peroxisomal β‐oxidation activities were significantly increased after DHA‐PL supplementation. These data indicated that the biological effects of PL with different fatty acid compositions were not completely equivalent and DHA‐PL, rich in n‐3 PUFA, was more efficient in ameliorating obesity‐related metabolic disorders, especially the lipid metabolism, attributing to the better inhibition of SREBP‐1c mediated lipogenesis and the elevation of hepatic lipolysis. Practical applications: This research gives the public the guidance of the dietary intake of bioactive phospholipids from the perspective of nutrition and it supplies informational support for the development of functional foods containing DHA‐PL participating to the prevention of chronic metabolic diseases in humans. In another aspect, this research also provides an important direction for the development and utilization of marine aquatic raw materials since these materials are the best sources of n‐3 polyunsaturated fatty acid enriched‐phospholipids. Dietary egg yolk phospholipids, soybean phospholipids, and marine docosahexaenoic acid‐enriched phospholipids (DHA‐PL) could efficiently improve obesity‐related metabolic disorders in mice. Notably, DHA‐PL, rich in n‐3 PUFA, exhibited the best ameliorative effects, especially on the lipid metabolism, which could be attributed to the better inhibition of SREBP‐1c mediated lipogenesis and the elevation of hepatic lipolysis. Such findings would be useful in the development of functional foods containing DHA‐PL participating to prevent chronic metabolic disease in humans.

Comparative Analyses of EPA-Phosphatidylcholine, EPA-Lysophosphatidylcholine, and DHA-Lysophosphatidylcholine on DHA and EPA Repletion in N-3 PUFA-Deficient Mice

Comparative analyses of DHA-Phosphatidylcholine and recombination of DHA-Triglyceride with Egg-Phosphatidylcholine or Glycerylphosphorylcholine on DHA repletion in n-3 deficient mice.

Effects of Short-Term Supplementation with DHA-enriched Phosphatidylcholine and Phosphatidylserine on Lipid Profiles in the Brain and Liver of N-3 PUFA-deficient Mice in Early Life after Weaning

Replenishment of Docosahexaenoic Acid (DHA) in Dietary n-3-Deficient Mice Fed DHA in Triglycerides or Phosphatidylcholines after Weaning.

Effect of Dietary DHA-Phosphatidylserine on DHA Level of Body Tissues in Developing Mice

Effect of dietary docosahexaenoic acid (DHA) in phospholipids and triglycerides on DHA level in body tissues of infant mice

Comparative Study of DHA‐enriched Phospholipids and EPA‐enriched Phospholipids on Metabolic Disorders in Diet‐induced‐obese C57BL/6J Mice

Short-term supplementation of EPA-enriched ethanolamine plasmalogen increases the level of DHA in the brain and liver of n-3 PUFA deficient mice in early life after weaning

Comparative Study of EPA-enriched Phosphatidylcholine and EPA-enriched Phosphatidylserine on Lipid Metabolism in Mice.

Comparative Studies of DHA-enriched Phosphatidylcholine and Recombination of DHA-ethyl Ester with Egg Phosphatidylcholine on Ameliorating Memory and Cognitive Deficiency in SAMP8 Mice.

Analysis of Fatty Acid composition and Sensitivity to Dietary n-3 PUFA Intervention of Mouse n-3 PUFA-Enriched Tissues/Organs

Comparative Study on the Digestion and Absorption Characteristics of N-3 LCPUFA-enriched Phospholipids in the Form of Liposomes and Emulsions

Docosahexaenoic Acid‐enriched Phospholipids Exhibit Superior Effects on Obesity‐related Metabolic Disorders to Egg Yolk Phospholipids and Soybean Phospholipids in Mice

Short-Term Supplementation Of Dha As Phospholipids Rather Than Triglycerides Improve Cognitive Deficits Induced By Maternal Omega-3 Pufa Deficiency During The Late Postnatal Stage

Docosahexaenoic Acid-rich Phospholipid Supplementation: Effect on Behavior, Learning Ability, and Retinal Function in Control and n-3 Polyunsaturated Fatty Acid Deficient Old Mice

Comparative Study of Different Polar Groups of EPA‐Enriched Phospholipids on Ameliorating Memory Loss and Cognitive Deficiency in Aged SAMP8 Mice

Long-Term Effects of Docosahexaenoic Acid-Bound Phospholipids and the Combination of Docosahexaenoic Acid-Bound Triglyceride and Egg Yolk Phospholipid on Lipid Metabolism in Mice

Short Term Effects of Different Omega-3 Fatty Acid Formulation on Lipid Metabolism in Mice Fed High or Low Fat Diet

N-3 Polyunsaturated Fatty Acids in Phospholipid or Triacylglycerol Form Attenuate Nonalcoholic Fatty Liver Disease Via Mediating Cannabinoid Receptor 1/adiponectin/ceramide Pathway.

Effects of Short-term Consumption of Fish Oil-egg-phospholipid on Lipid Metabolism in Mice Fed a High-fat Diet

Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.